Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.92 EUR | +0.30% | +0.89% | -0.08% |
08:33am | Sanofi Gets US FDA’s Priority Review for Expanded Use of Blood Cancer Drug Sarclisa | MT |
08:10am | Sanofi: FDA grants priority review in myeloma | CF |